Clinical trial Recruiting at 1 site Phase 4 Interventional Ages 18 and up

Preventing infections in hemodialysis patients during catheter placement with antibiotics

Official title: Preventive Antibiotic Treatment Before Insertion or Exchange of Tunneled Cuffed Catheters in Hemodialysis Patients to Prevent Early Catheter-Related Infections

Run by Western Galilee Hospital-Nahariya · NCT06814223 · Data updated 2026-11-12

This study tests if giving antibiotics before catheter placement can help prevent infections in hemodialysis patients who are at high risk.

More Catheter-Associated Urinary Tract Infection trials

Quick facts

PhasePhase 4
Study typeInterventional
Ages18 Years and up
SexAll
Enrollment200 (estimated)
SponsorWestern Galilee Hospital-Nahariya
Government
Locations1 site (Nahariya, Israel)
StatusRecruiting
StartedOctober 28, 2024
Main results expectedDecember 30, 2027
Study endsJune 30, 2028
Registry record updatedFebruary 7, 2025
Trial IDNCT06814223 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include hemodialysis patients scheduled for new tunneled catheter placement or replacement who have a history of atrial fibrillation, heart failure, or require a femoral catheter.

Probably not a fit

Patients unable to provide informed consent or those undergoing prolonged antibiotic therapy prior to catheter insertion may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to evaluate the effectiveness of prophylactic antibiotics in reducing early catheter-related infections among hemodialysis patients at high risk. Participants will be randomized into two groups: one receiving antibiotics such as cefamezine and gentamicin, and the other receiving no antibiotics before catheter placement. The study will assess the incidence of infections and secondary complications within 45 days of catheter insertion. The goal is to determine if antibiotic administration can significantly lower infection rates and associated morbidity and mortality.

Why it matters

Potential benefit: If successful, this approach could significantly reduce the incidence of infections and improve outcomes for hemodialysis patients.

How similar studies have gone: Other studies have shown promising results with prophylactic antibiotics in similar high-risk populations, indicating potential for success in this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Hemodialysis patients scheduled for new tunneled catheter placement or replacement of an existing tunneled catheter.
* Prior diagnosis of at least one of the following conditions:

  1. Atrial fibrillation
  2. Heart failure
  3. Femoral tunneled catheter

     * Patients who have signed informed consent to participate in the study.

Exclusion Criteria:

* • Hemodialysis patients unable to provide informed consent and requiring a legal guardian.

  * Patients undergoing prolonged antibiotic therapy prior to tunneled catheter insertion.

Where it's running

  • Galilee Medical Center
    Nahariya, Israel, Israel
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.